Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DiaMedica Therapeutics Inc.DMAC · Entity 5813 | 10% owner | November 17, 2025 | December 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DiaMedica Therapeutics Inc.
Report date November 17, 2025 · Filed December 08, 2025
Jointly reported with TRILL AB
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectSee Footnote | 8,825,742 |
Last balance in matching sequence
After 2025-11-25 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
7 source rowsRow 1 · 2025-11-17 · Purchase · Acquired 187,393 · Balance 7,951,858 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 2 · 2025-11-18 · Purchase · Acquired 182,882 · Balance 8,134,740 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 3 · 2025-11-19 · Purchase · Acquired 240,352 · Balance 8,375,092 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 4 · 2025-11-20 · Purchase · Acquired 128,426 · Balance 8,503,518 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 5 · 2025-11-21 · Purchase · Acquired 208,872 · Balance 8,712,390 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 6 · 2025-11-24 · Purchase · Acquired 40,253 · Balance 8,752,643 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Row 7 · 2025-11-25 · Purchase · Acquired 73,099 · Balance 8,825,742 F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 25, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 73,099 | $8.57 | $626,816.62 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 7 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,825,742 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 24, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 40,253 | $7.89 | $317,720.95 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 6 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,752,643 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 21, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 208,872 | $7.41 | $1,547,574.42 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 5 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,712,390 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 20, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 128,426 | $7.41 | $951,212.85 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 4 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,503,518 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 19, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 240,352 | $7.21 | $1,732,361.08 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 3 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,375,092 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 18, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 182,882 | $6.75 | $1,234,618.09 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 2 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,134,740 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| November 17, 2025 Filed Dec 8, 2025 22:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 187,393 | $6.52 | $1,221,165.22 |
DisclosureSEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 1 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,951,858 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 27, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 50,772 | $6.00 | $304,632.00 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 9 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,764,465 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 26, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 59,648 | $6.00 | $357,888.00 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 8 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,713,693 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 25, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 338,265 | $6.00 | $2,029,251.74 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 7 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,654,045 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 22, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 59,788 | $5.96 | $356,575.63 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 6 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,315,780 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 21, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 48,172 | $5.96 | $287,028.04 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 5 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,255,992 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 20, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 71,107 | $5.86 | $416,495.03 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 4 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,207,820 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 15, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 8,233 | $6.00 | $49,398.00 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 3 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,136,713 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 14, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 70,414 | $5.99 | $421,920.69 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 2 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,128,480 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| August 13, 2025 Filed Sep 4, 2025 18:29 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 293,601 | $5.91 | $1,734,917.67 |
DisclosureSEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 1 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,058,066 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| July 23, 2025 Filed Jul 25, 2025 22:54 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 1,542,857 | $3.50 | $5,399,999.50 |
DisclosureSEC source: 0001104659-25-070920 · tm2521564-1_4seq1.xml · nonDerivative · entry 1 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote 1 Disclosed balance after: 6,764,465 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:24 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseCommon Shares | 1,200,000 | $2.50 | $3,000,000.00 |
DisclosureSEC source: 0001104659-24-076840 · tm2418593-1_4seq1.xml · nonDerivative · entry 1 STAHLBERG JAN · CIK 0001983161 · 10% owner TRILL AB · CIK 0001887436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote 1 Disclosed balance after: 5,221,608 F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.